Long-term Outcomes and Patterns of Failure Following Trimodality Treatment With Bladder Preservation for Invasive Bladder Cancer
Authors:
Abstract
No abstract availableKeywords
This publication has 31 references indexed in Scilit:
- Cancer incidence and mortality patterns in Europe: Estimates for 40 countries in 2012European Journal of Cancer, 2013
- Management of local recurrences in the irradiated bladder: a systematic reviewBJU International, 2012
- Long-term Results of Two Prospective Bladder-sparing Trimodality Approaches for Invasive Bladder Cancer: Neoadjuvant Chemotherapy and Concurrent Radio-chemotherapyUrology, 2012
- Updated results of bladder-sparing trimodality approach for invasive bladder cancerUrologic Oncology: Seminars and Original Investigations, 2010
- Late Pelvic Toxicity After Bladder-Sparing Therapy in Patients With Invasive Bladder Cancer: RTOG 89-03, 95-06, 97-06, 99-06Journal of Clinical Oncology, 2009
- Phase I-II RTOG Study (99-06) of Patients With Muscle-Invasive Bladder Cancer Undergoing Transurethral Surgery, Paclitaxel, Cisplatin, and Twice-daily Radiotherapy Followed by Selective Bladder Preservation or Radical Cystectomy and Adjuvant ChemotherapyUrology, 2009
- Defining Early Morbidity of Radical Cystectomy for Patients with Bladder Cancer Using a Standardized Reporting MethodologyEuropean Urology, 2009
- Management of Superficial Recurrences in an Irradiated Bladder After Combined-Modality Organ-Preserving TherapyInternational Journal of Radiation Oncology - Biology - Physics (IJROBP), 2008
- Phase I study of conformal radiotherapy with concurrent gemcitabine in locally advanced bladder cancerInternational Journal of Radiation Oncology - Biology - Physics (IJROBP), 2005
- Organ Conservation in Invasive Bladder Cancer by Transurethral Resection, Chemotherapy and Radiation: Results of a Urodynamic and Quality of Life Study on Long-term SurvivorsJournal of Urology, 2003